The Mediterranean Diet for Irritable Bowel Syndrome
Annals of Internal Medicine · 2025-12 · 178 (12) · 1709-1717
DOI: 10.7326/annals-25-01519 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Annals of Internal Medicine, 2025-12. Verfasst von Joy O Bamidele und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, United Kingdom (J.O.B., G.M.B., R.M.F., …. Hauptthemen laut MEDLINE: Diet, Mediterranean, Irritable Bowel Syndrome. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Patients with irritable bowel syndrome (IBS) frequently seek dietary advice, but few evidence-based options exist. Major societal guidelines recommend traditional dietary advice (TDA) as first-line therapy, with the cumbersome and resource-intensive low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet reserved as second-line therapy. Recent pilot data suggest that the Mediterranean diet (MD), renowned for its general health benefits, improves IBS symptoms, but whether it can be considered another first-line dietary option is unknown. OBJECTIVE: To determine if the MD is noninferior to TDA in managing IBS symptoms. DESIGN: Randomized noninferiority clinical trial. (ClinicalTrials.gov: NCT05985018). SETTING: Online virtual platform. PARTICIPANTS: 139 persons with IBS from across the United Kingdom. INTERVENTION: 6 weeks of the MD (n = 68) or TDA (n = 71). MEASUREMENTS: Primary end point was the proportion achieving clinical response, defined as 50-point or greater reduction in IBS Symptom Severity Scale (IBS-SSS). Secondary outcomes included changes in IBS-SSS scores, psychological health, somatic symptom reporting, quality of life, diet satisfaction, and Mediterranean Diet Adherence Screener (MEDAS). RESULTS: Baseline characteristics (mean age, 40.4 years [range, 19 to 65 years]; 80% women) and IBS-SSS (mean, 309 [SD, 90]) were similar between groups. On modified intention-to-treat analysis, the primary end point was met by 62% (95% CI, 50% to 73%) following a MD versus 42% (CI, 31% to 55%) following TDA. The difference in clinical response favored the MD (difference, 20 percentage points [CI, 4 to 36 percentage points]; P = 0.017), demonstrating noninferiority and superiority. There was a greater reduction in the mean IBS-SSS after a MD than TDA (-101.2 vs. -64.5; Δ-36.7 [CI,-70.5 to -2.8]; P = 0.034). No statistically significant differences were seen between the groups with regard to changes in mood, somatic symptoms, quality of life, or diet satisfaction. The MEDAS significantly increased after a MD compared with TDA (P < 0.001). LIMITATION: No long-term data. CONCLUSION: The MD showed noninferiority and superiority to TDA in managing IBS symptoms. It represents a viable first-line dietary intervention for IBS. PRIMARY FUNDING SOURCE: None.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, United Kingdom (J.O.B., G.M.B., R.M.F., M.G.S.).
- Department of Gastroenterology and Department of Dietetics, Sheffield Teaching Hospitals, Sheffield, United Kingdom (R.L.B., C.C.S.).
- Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, and Department of Gastroenterology, Sheffield Teaching Hospitals, Sheffield, United Kingdom (I.A.).
ORCID-Profile: Mohamed G Shiha, Imran Aziz
Zitieren
APA
Bamidele, J. O., Brownlow, G. M., Flack, R. M., Buckle, R. L., Shaw, C. C., Shiha, M. G., & Aziz, I. (2025). The Mediterranean Diet for Irritable Bowel Syndrome. Annals of Internal Medicine, 178(12), 1709-1717. https://doi.org/10.7326/annals-25-01519
Vancouver
Bamidele JO, Brownlow GM, Flack RM, Buckle RL, Shaw CC, Shiha MG, et al. The Mediterranean Diet for Irritable Bowel Syndrome. Annals of Internal Medicine. 2025;178(12):1709-1717. doi:10.7326/annals-25-01519
BibTeX
@article{Bamidele2025,
author = {Bamidele, Joy O and Brownlow, Grace M and Flack, Rosie M and Buckle, Rachel L and Shaw, Christian C and Shiha, Mohamed G and Aziz, Imran},
title = {The Mediterranean Diet for Irritable Bowel Syndrome},
journal = {Annals of Internal Medicine},
year = {2025},
volume = {178},
number = {12},
pages = {1709--1717},
doi = {10.7326/annals-25-01519}
}
EUVIMED